The DOI matches its Crossref record.
Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice
Abstract
Adenosine released into the extracellular space by immunologic and nonimmunologic stimuli has been shown to regulate various immune functions. In this study we report that i.p. pretreatment of mice with CGS-21680 HCl (CGS), a selective agonist of A2 adenosine receptors, at 0.2 to 2 mg/kg caused an augmentation of plasma IL-10 levels induced by i.p. injection of LPS, but decreased plasma levels of LPS-induced TNF-alpha. 2-Chloro-N6-cyclopentyladenosine (CCPA), an agonist of A1 adenosine receptors, at 0.5 mg/kg diminished LPS-induced plasma TNF-alpha concentrations, but enhanced LPS-induced IL-10 levels only at the highest dose used (2 mg/kg). The specific A3 adenosine receptor agonist 1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-beta- D-ribofuranuronamide, at 0.2 and 0.5 mg/kg potentiated LPS-stimulated IL-10 production and inhibited LPS-induced TNF-alpha production. LPS-induced plasma nitrite and nitrate levels (the breakdown products of nitric oxide (NO)) were suppressed by CGS and CCPA. In the RAW 264.7 macrophage cell line, pretreatment of the cells with both CGS and CCPA inhibited LPS-induced IL-10, TNF-alpha, and NO production, each in a concentration-dependent manner. The inhibitory effect of these drugs on cytokine and NO production was associated with improved mitochondrial respiration. Neither CGS nor CCPA affected the LPS-induced nuclear translocation of transcription factor nuclear factor-kappaB in these cells. These results demonstrate that adenosine receptor stimulation differentially modulates the LPS-induced production of IL-10, TNF-alpha, and NO in vitro and in vivo. The increase in LPS-induced IL-10 production and suppression of LPS-induced TNF-alpha and NO production caused by adenosine receptor activation may explain some of the immunomodulatory actions of adenosine released in excess during inflammatory and/or ischemic insult.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Elenkov, I. J., Wilder, R. L., Chrousos, G. P., & Vizi, E. S. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01470-4 · Cited by 2,252
Self-citationBours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.013 · Cited by 1,030
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 899
Self-citationPharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Immunity, inflammation and cancer: a leading role for adenosine
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3613 · Cited by 765
Self-citationAustin, P. J., & Moalem-Taylor, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.013 · Cited by 607
Extracellular adenosine triphosphate and adenosine in cancer
Stagg, J., & Smyth, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.292 · Cited by 571
Haskó, G., Kuhel, D. G., Chen, J.-F., Schwarzschild, M. A., Deitch, E. A., Mabley, J. G., Marton, A., & Szabó, C. (2000) · The FASEB Journal · doi:10.1096/fj.99-0508com · Cited by 512
Self-citationMacrophages and the maintenance of homeostasis
Mosser, D. M., Hamidzadeh, K., & Goncalves, R. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00541-3 · Cited by 505
Cytokine Dysregulation, Inflammation and Well-Being
Elenkov, I. J., Iezzoni, D. G., Daly, A., Harris, A. G., & Chrousos, G. P. (2005) · Neuroimmunomodulation · doi:10.1159/000087104 · Cited by 502
Expression analysis of G Protein-Coupled Receptors in mouse macrophages
Lattin, J. E., Schroder, K., Su, A. I., Walker, J. R., Zhang, J., Wiltshire, T., Saijo, K., Glass, C. K., Hume, D. A., Kellie, S., et al. (2008) · Immunome Research · doi:10.1186/1745-7580-4-5 · Cited by 438
Macrophages and the Recovery from Acute and Chronic Inflammation
Hamidzadeh, K., Christensen, S. M., Dalby, E., Chandrasekaran, P., & Mosser, D. M. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034348 · Cited by 437
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis
CUTOLO, M., SULLI, A., PIZZORNI, C., SERIOLO, B., & STRAUB, R. H. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.8.729 · Cited by 433
Molecular Aspects of Parasite-Vector and Vector-Host Interactions in Leishmaniasis
Sacks, D., & Kamhawi, S. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.453 · Cited by 432
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Vigano, S., Alatzoglou, D., Irving, M., Ménétrier-Caux, C., Caux, C., Romero, P., & Coukos, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00925 · Cited by 420
Adenosine promotes alternative macrophage activation via A2A and A2B receptors
Csóka, B., Selmeczy, Z., Koscsó, B., Németh, Z. H., Pacher, P., Murray, P. J., Kepka‐Lenhart, D., Jr., S. M. M., Gause, W. C., Leibovich, S. J., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-190934 · Cited by 376
Self-citationRegulation of Inflammation by Adenosine
Haskó, G., & Cronstein, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00085 · Cited by 367
Self-citationHaskó, G., Kuhel, D. G., Németh, Z. H., Mabley, J. G., Stachlewitz, R. F., Virág, L., Lohinai, Z., Southan, G. J., Salzman, A. L., & Szabó, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1013 · Cited by 334
Tsutsui, S., Schnermann, J., Noorbakhsh, F., Henry, S., Yong, V. W., Winston, B. W., Warren, K., & Power, C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4271-03.2004 · Cited by 323
Immunomodulatory and neuroprotective effects of inosine
Haskó, G., Sitkovsky, M. V., & Szabó, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.01.006 · Cited by 308
Self-citationDisruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells
Salvatore, C. A., Tilley, S. L., Latour, A. M., Fletcher, D. S., Koller, B. H., & Jacobson, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4429 · Cited by 303
Miller, L. E., Jüsten, H., Schcölmerich, J., & Straub, R. H. (2000) · The FASEB Journal · doi:10.1096/fj.99-1082com · Cited by 294
Németh, Z. H., Lutz, C. S., Csóka, B., Deitch, E. A., Leibovich, S. J., Gause, W. C., Tone, M., Pacher, P., Vizi, E. S., & Haskó, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8260 · Cited by 291
Self-citationTumor-promoting functions of adenosine
Spychala, J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00053-x · Cited by 284
Pinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G.-J., & Leibovich, S. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63698-x · Cited by 278
Lee, C., Shin, J., Lee, J. S., Byun, E., Ryu, J. H., Um, S. H., Kim, D.-I., Lee, H., & Cho, S.-W. (2013) · Biomacromolecules · doi:10.1021/bm400352d · Cited by 278
Elenkov, I. J. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.037 · Cited by 273
Brightbill, H. D., Plevy, S. E., Modlin, R. L., & Smale, S. T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1940 · Cited by 268
Esechie, A., Kiss, L., Olah, G., Horváth, E. M., Hawkins, H., Szabo, C., & Traber, D. L. (2008) · Clinical Science · doi:10.1042/cs20080021 · Cited by 267
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
Li, X.-Y., Moesta, A. K., Xiao, C., Nakamura, K., Casey, M., Zhang, H., Madore, J., Lepletier, A., Aguilera, A. R., Sundarrajan, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0541 · Cited by 264
Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases
Cronstein, B. N., & Sitkovsky, M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.178 · Cited by 258
Gilad, E., Wong, H. R., Zingarelli, B., Virág, L., O'connor, M., Salzman, A. L., & Szabó, C. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.9.685 · Cited by 252
Self-citationStaphylococcus aureus synthesizes adenosine to escape host immune responses
Thammavongsa, V., Kern, J. W., Missiakas, D. M., & Schneewind, O. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090097 · Cited by 252
Neuroendocrine Regulation of IL‐12 and TNF‐α/IL‐10 Balance: Clinical Implications
ELENKOV, I. J., CHROUSOS, G. P., & WILDER, R. L. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05374.x · Cited by 158
Tacchini, L., Gammella, E., De Ponti, C., Recalcati, S., & Cairo, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800365200 · Cited by 132
Bitto, A., Polito, F., Irrera, N., D'Ascola, A., Avenoso, A., Nastasi, G., Campo, G. M., Micali, A., Bagnato, G., Minutoli, L., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30538 · Cited by 105
Modulation of Macrophage Phenotype by Soluble Product(s) Released from Neutrophils
Daley, J. M., Reichner, J. S., Mahoney, E. J., Manfield, L., Henry, W. L., Mastrofrancesco, B., & Albina, J. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2265 · Cited by 101
Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy
Hatfield, S. M., & Sitkovsky, M. V. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137554 · Cited by 73
Parages, M. L., Rico, R. M., Abdala-Díaz, R. T., Chabrillón, M., Sotiroudis, T. G., & Jiménez, C. (2012) · Journal of Applied Phycology · doi:10.1007/s10811-012-9814-4 · Cited by 49
Anti-inflammatory Effect of DNA Polymeric Molecules in a Cell Model of Osteoarthritis
Baek, A., Kim, M., Kim, S. H., Cho, S.-R., & Kim, H. J. (2018) · Inflammation · doi:10.1007/s10753-017-0722-2 · Cited by 33
Ubiquitination mediates Kv1.3 endocytosis as a mechanism for protein kinase C-dependent modulation
Martínez-Mármol, R., Styrczewska, K., Pérez-Verdaguer, M., Vallejo-Gracia, A., Comes, N., Sorkin, A., & Felipe, A. (2017) · Scientific Reports · doi:10.1038/srep42395 · Cited by 27
Anti Inflammatory Property of PDRN—An in Vitro Study on Cultured Macrophages
Castellini, C., Belletti, S., Govoni, P., & Guizzardi, S. (2017) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2017.81002 · Cited by 17
“In particular, adenosine A2A receptors are present in the monocyte-macrophage cell line [30] and, as a result of interaction with adenosine or agonists, these agents have been shown to be able to modulate macrophage functions, such as nitric oxide (NO) production, and to regulate cytokine production both in vitro and…”
BackgroundMethod(2015) · PubMed · Cited by 8
Metadata
- Authors
- Haskó, G., Szabó, C., Németh, Z. H., Kvetan, V, Pastores, S. M., & Vizi, E. S.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-11
- Volume
- 157
- Issue
- 10
- Pages
- 4634-4640
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1575186397
- Cited by
- 536
- References
- 0
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.